Clinical study on the efficacy and safety of bevacizumab combined with TAS-102 in the second-line treatment of advanced colorectal cancer
收藏NIAID Data Ecosystem2026-03-13 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/38796
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: test group:Bevacizumab in combination with TAS-102
Primary outcome(s): Progression Free Survival (PFS)
Study Design: Single arm
创建时间：
2022-04-15
